Chinook Therapeutics Inc reports results for the quarter ended in March - Earnings Summary

Chinook Therapeutics

12/05/2022 22:03

* Chinook Therapeutics Inc  KDNY.OQ  reported a quarterly
adjusted
loss of 54 cents​​ per share for the quarter ended in March. The
mean expectation of five analysts for the quarter was for a loss
of 67 cents per share.
    * Revenue rose 668.4% to $2.70 million from a year ago; 
analysts
expected zero. 
    * Chinook Therapeutics Inc's reported EPS for the quarter
was a
loss of 54 cents​.
    * The mean earnings estimate of analysts had fallen by
about 1.3%
in the last three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * Chinook Therapeutics Inc shares had fallen by 18.9% this
quarter and lost 18.6% so far this year.
    * The company reported a quarterly loss of $31.68 million.
    * Wall Street's median 12-month price target for Chinook
Therapeutics Inc is $29.00 
    * The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 8 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell." 

This summary was machine generated May 12 at 09:02 p.m.  ​All
figures in US dollars unless otherwise stated